Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity

Abstract

Mutations in the gene encoding the amyloid protein precursor (APP) cause autosomal dominant Alzheimer's disease1,2,3. Cleavage of APP by unidentified proteases, referred to as β- and γ-secretases4,5,6,7, generates the amyloid β-peptide, the main component of the amyloid plaques found in Alzheimer's disease patients8. The disease-causing mutations flank the protease cleavage sites in APP and facilitate its cleavage. Here we identify a new membrane-bound aspartyl protease (Asp2) with β-secretase activity. The Asp2 gene is expressed widely in brain and other tissues. Decreasing the expression of Asp2 in cells reduces amyloid β-peptide production and blocks the accumulation of the carboxy-terminal APP fragment that is created by β-secretase cleavage. Solubilized Asp2 protein cleaves a synthetic APP peptide substrate at the β-secretase site, and the rate of cleavage is increased tenfold by a mutation associated with early-onset Alzheimer's disease in Sweden3. Thus, Asp2 is a new protein target for drugs that are designed to block the production of amyloid β-peptide peptide and the consequent formation of amyloid plaque in Alzheimer's disease.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Asp2 functional domains, tissue distribution and amino-acid sequence.
Figure 2: Asp2 antisense oligomers decrease amyloid β-peptide processing.
Figure 3: Asp2 increases production of the APP C-terminal β-secretase product.
Figure 4: Asp2 increases Aβ peptide release.
Figure 5: Asp2 β-secretase cleavage activity.

Similar content being viewed by others

References

  1. Goate,A. et al. Segregation of a missense mutation in the amyloid protein precursor protein gene with familial Alzheimer's disease. Nature 349, 704–705 (1991).

    Article  ADS  CAS  Google Scholar 

  2. Murrell,J., Farlow,M., Ghetti,B. & Benson,M. D. A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science 254, 97–99 (1991).

    Article  ADS  CAS  Google Scholar 

  3. Mullan,M. et al. A pathogenic mutation for probably Alzheimer's disease in the APP gene at the N-terminus of beta amyloid. Nature Genet. 1, 345–347 (1992).

    Article  CAS  Google Scholar 

  4. Cai,X. D., Golde,T. E. & Younkin,S. G. Release of excess amyloid beta protein from a mutant amyloid beta protein precursor. Science 259, 514–516 (1993).

    Article  ADS  CAS  Google Scholar 

  5. Citron,M. et al. Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. Nature 360, 372–374 (1992).

    Article  Google Scholar 

  6. Suzuki,N. et al. An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science 264, 1336–1340 (1994).

    Article  ADS  CAS  Google Scholar 

  7. Selkoe,D. J. The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol. 8, 447–453 (1998).

    Article  CAS  Google Scholar 

  8. Glenner,G. G. & Wong,C. W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloidogenic derivative. Science 255, 728–730 (1984).

    Google Scholar 

  9. Ladror,U. S., Snyder,S. W., Wang,G. T., Holzman,T. F. & Krafft,G. A. Cleavage at the amino and carboxyl termini of Alzheimer's amyloid-beta by cathepsin D. J. Biol. Chem. 269, 18422–18428 (1994).

    CAS  PubMed  Google Scholar 

  10. Dreyer,R. N. et al. Processing of the pre-beta-amyloid protein by cathepsin D is enhanced by a familial Alzheimer's disease mutation. Eur. J. Biochem. 224, 265–271 (1994).

    Article  CAS  Google Scholar 

  11. Saftig,P. et al. Amyloidogenic processing of human amyloid precursor protein in hippocampal neurons devoid of cathepsin D. J. Biol. Chem. 271, 27241–27244 (1996).

    Article  CAS  Google Scholar 

  12. Tatnell, P. J. et al. Napsins: new human aspartic proteinases. Distinction between two closely related genes. FEBS Lett. 441, 43–48 (1994).

    Article  Google Scholar 

  13. Neill,D., Hughes,D., Edwardson,B. K., Rima,B. K. & Allsop,D. Human IMR-32 neuroblastma cells as a model cell line in Alzheimer's Disease research. J. NeuroSci. Res. 39, 482–493 (1994).

    Article  CAS  Google Scholar 

  14. Asami-Odaka,A., Ishibashi,Y., Kikuchi,T., Kitada,C. & Suzuki,N. Long amyloid β-protein secreted from wild-type human neuroblastoma IMR-32 cells. Biochemistry 34, 10272–10278 (1995).

    Article  CAS  Google Scholar 

  15. De Strooper,B. et al. Deficiency of presenilin 1 inhibits cleavage of amyloid precursor protein. Nature 391, 387–390 (1998).

    Article  ADS  CAS  Google Scholar 

  16. Naruse,S. et al. Effects of PS1 deficiency on membrane protein trafficking in neurons. Neuron 21, 1213–1221 (1998).

    Article  CAS  Google Scholar 

  17. Vassar,R. et al. β-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286, 735–741 (1999).

    Article  CAS  Google Scholar 

  18. Hussain,I. et al. Identification of a novel aspartic protease (Asp2) as β-secretase. Molec. Cell. Neurosci. [online] 〈http://www.apnet.com/www/journal/cn/mcne.1999.0811〉

  19. Pirttila,T. et al. Longitudinal study of cerebrospinal fluid amyloid proteins and apoliproprotein E in patients with probably Alzheimer's disease. Neurosci. Lett. 249, 21–24 (1998).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank C. Himes, M. Fairbanks, J. Leone, T. Emmons, R. Drong, J. Slightom, G. Winterrowd and D. McKinley for their help, and J. McCall for his unflagging support and good humour.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Riqiang Yan or Mark E. Gurney.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yan, R., Bienkowski, M., Shuck, M. et al. Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity. Nature 402, 533–537 (1999). https://doi.org/10.1038/990107

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/990107

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing